FIELD: medicine, pharmacy. SUBSTANCE: proposed agent has adenosine and riboxine at the following ratio, mas. p.: adenosine 1, and riboxine 1.5-2.5. Medicinal agent is prepared by dissolving adenosine and riboxine at heating, solution is kept at 50-65 C for 5-15 min, cooled and pH value is brought about to 6-8. Then solution is filtered, dosed into ampoules, sealed and sterilized. EFFECT: enhanced therapeutic effectiveness, stability at storage as an aqueous solutions.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREPARING OF AGENT FOR CARDIOVASCULAR DISEASE TREATMENT | 1990 |
|
SU1769428A1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF SOLUTION FOR INJECTIONS OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE AND PYRIDOXIN, METHOD OF ITS OBTAINING AND METHOD OF TREATMENT | 2008 |
|
RU2383331C1 |
| ANTIOXIDANT PREPARATION FOR TREATMENT AND PREVENTION OF CARDIAC PATHOLOGIES IN ANIMALS | 2023 |
|
RU2818764C1 |
| DRUG COMPOSITION OF CYTOPROTECTIVE ACTION AND METHOD FOR PRODUCTION THEREOF | 2017 |
|
RU2651047C1 |
| METHOD OF PREPARING OF PURINE-CONTAINING PRODUCTS | 1991 |
|
RU2027762C1 |
| PHARMACEUTICAL FORMULATION FOR TREATING DISEASES ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION | 2012 |
|
RU2504375C1 |
| SOLUTION FOR INJECTIONS CONTAINING NALBUPHINE | 2012 |
|
RU2483731C1 |
| METHOD FOR GLIBENCLAMIDE PHARMACEUTICAL COMPOSITION PREPARATION IN FORM OF INJECTION SOLUTION | 2016 |
|
RU2615368C1 |
| METHOD OF PREPARING INJECTION FORM OF CHONDROITIN SULFATE | 2015 |
|
RU2677330C2 |
| UBIQUINOL COMPOSITION FOR PARENTERAL ADMINISTRATION AND METHOD FOR ITS PRODUCTION | 2016 |
|
RU2635993C1 |
